As introduced: - Prohibits various public boards, including the board of pharmacy, from granting regulatory mitigation or waiving or modifying rules related to dispensing, prescribing, administering, or distributing medications or controlled substances to any person or business developing artificial intelligence for use in such medication-related activities. - Defines artificial intelligence as a technology system that is trained on data, designed to simulate human conversation through text, audio, or visual communication, and generates nonscripted outputs similar to human outputs with limited or no human oversight.
| Date | Chamber | Action |
|---|---|---|
May 7, 2026 | S | Second Read and Referred S Emerging Issues and Professional Registration Committee |
Feb 26, 2026 | S | S First Read |
| Last Action | May 7, 2026 |
|---|---|
| Year | 2026 |
| Bill Type | Bill |
| Created | Mar 21, 2026 |
| Updated | May 8, 2026 |